Prefer To Send A Donation By Mail?
You can also mail your gift to:
The Bili Project Foundation
303 N. Glenoaks Blvd. Suite 700
Burbank, CA 91502
The Bili Project Foundation is a registered 501(c)(3). Your charitable contribution to The Bili Project Foundation is tax deductible.
WHERE THE MONEY GOES
$25 – Provides general support for Hepatobiliary Cancer Research Efforts; when pooled together, we can support a broad range of research
$50 – Cost of collecting, processing, and banking blood samples for future biomarker and/or genomic research on causes and molecular pathways of Hepatobiliary cancers, which are needed for discovery of new biomarkers, early detection, prognosis, or molecular profiling of the cancer
$100 – Cost of processing fresh tumor samples in culture medium and sending samples for development of tumor xenografts or cell lines to study new drugs and targets in the laboratory
$250 – Research support for oncology fellow to study Cholangiocarcinoma and other Hepatobiliary cancers with Cholangiocarcinoma Collaborative Physicians
$300 – Cost of collecting, processing, and banking fresh tumor samples for research (roughly, $250‐500 for 1 patient’s tumor, depending on complexity)
$400 – Support for the dedicated research coordinator to facilitate patient consent process, review of patients’ charts, contact patients, and perform data entry to study outcomes associated with specific risk factors and/or tumor genomic findings
$500 – Support for Hepatobiliary cancer research physician to dedicate his/her time to work on a broad range of research projects related to these cancers, including biomarker studies and clinical trials of novel drugs
$60,000 – Annually Maintaining the UCSF Hepatobiliary Tissue Tumor Bank, which will allow UCSF to continue to build the inventory of the bank and maintain the currently banked specimens by supporting supplies, freezer space, and technician time
$75,000 - $100,000 – The cost of conducting new research studies on Hepatobiliary cancer specimens to include clinical trials for Hepatobiliary Cancer Patients.